Nasdaq - Delayed Quote USD

Fidelity Select Biotechnology Portfolio (FBIOX)

16.66
-0.41
(-2.40%)
As of 8:09:16 AM EDT. Market Open.
Loading Chart for FBIOX
  • Previous Close 17.07
  • YTD Return -2.23%
  • Expense Ratio 0.63%
  • Category Health
  • Last Cap Gain 31.00
  • Morningstar Rating
  • Morningstar Risk Rating High
  • Sustainability Rating
  • Net Assets 3.9B
  • Beta (5Y Monthly) 0.54
  • Yield 1.24%
  • 5y Average Return --
  • Holdings Turnover 38.00%
  • Last Dividend 0.06
  • Inception Date Dec 16, 1985

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Fidelity Investments

Fund Family

Health

Fund Category

3.9B

Net Assets

1985-12-16

Inception Date

Performance Overview: FBIOX

View More

Trailing returns as of 5/13/2025. Category is Health.

YTD Return

FBIOX
2.23%
Category
7.95%
 

1-Year Return

FBIOX
6.07%
Category
30.16%
 

3-Year Return

FBIOX
10.42%
Category
16.10%
 

5-Year Return

FBIOX
3.61%
Category
15.71%
 

People Also Watch

Holdings: FBIOX

View More

Sector Weightings

SectorFBIOX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: FBIOX

View More

Research Reports: FBIOX

View More

Top Mutual Funds